On Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) opened lower -7.71% from the last session, before settling in for the closing price of $5.06. Price fluctuations for TERN have ranged from $3.26 to $14.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. Company’s average yearly earnings per share was noted -9.26% at the time writing. With a float of $41.12 million, this company’s outstanding shares have now reached $64.58 million.
Let’s determine the extent of company efficiency that accounts for 66 employees.
Terns Pharmaceuticals Inc (TERN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Terns Pharmaceuticals Inc is 36.39%, while institutional ownership is 76.31%. The most recent insider transaction that took place on Apr 03 ’24, was worth 856,009. In this transaction 10% Owner of this company sold 138,066 shares at a rate of $6.20, taking the stock ownership to the 268,573 shares. Before that another transaction happened on Apr 02 ’24, when Company’s 10% Owner sold 101,480 for $6.65, making the entire transaction worth $674,842. This insider now owns 272,722 shares in total.
Terns Pharmaceuticals Inc (TERN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -9.26% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Check out the current performance indicators for Terns Pharmaceuticals Inc (TERN). In the past quarter, the stock posted a quick ratio of 22.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Looking closely at Terns Pharmaceuticals Inc (NASDAQ: TERN), its last 5-days average volume was 0.76 million, which is a drop from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 6.77%. Additionally, its Average True Range was 0.50.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 21.22%, which indicates a significant increase from 0.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.01% in the past 14 days, which was lower than the 87.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.66, while its 200-day Moving Average is $6.03. However, in the short run, Terns Pharmaceuticals Inc’s stock first resistance to watch stands at $4.88. Second resistance stands at $5.10. The third major resistance level sits at $5.21. If the price goes on to break the first support level at $4.56, it is likely to go to the next support level at $4.45. Should the price break the second support level, the third support level stands at $4.23.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are currently 64,652K shares outstanding in the company with a market cap of 301.92 million. Presently, the company’s annual sales total 0 K according to its annual income of -90,210 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -21,020 K.
